Snap Chart
In a recent Bain survey, 61% of pharma executives said they expect big data and analytics to have a major impact on the industry in the next five years, transforming areas such as predictive analytics for diagnoses and supply chain tracking. Nearly half said cybersecurity technologies and cloud services will remain critical as pharma companies attempt to protect sensitive health data while managing costs.
Jason Evers is a partner in Bain & Company’s Healthcare practice and is based in the firm’s Chicago office.
First published in aprile 2019